Rich Yang
Biosensing Advisor
Rich Yang is a metabolic health innovator and executive with more than 25 years of experience in biosensors, digital health, and commercial strategy.
As GOLD’s first biosensing advisor, he guided the pioneering use of CGM with non-diabetic athletes at the 2012 London Olympics, contributing to medal-winning performances and redefining elite performance tracking.
Now CEO of Biolinq, Rich has led a next-generation biosensing platform and raised over $300M to bring breakthrough wearables to market, and guides GOLD’s biosensing strategy, turning continuous biomarker data into personalized, actionable insights through the AI-powered platform.